Tag Archives: Acute

FDA Approves Tosymra (sumatriptan) Nasal Spray for Acute Treatment of Migraine

FDA Approves Tosymra (sumatriptan) Nasal Spray for Acute Treatment of Migraine Print this page January 27, 2019 — Dr. Reddy’s Laboratories Ltd. and its subsidiary, Promius Pharma, LLC today announced the approval of Tosymra (previously known as DFN-02) by the U.S. Food and Drug Administration (FDA). Tosymra is indicated for the acute treatment of migraine… Read More »

Sprycel (dasatinib) Tablets Now Approved in Combination with Chemotherapy in Certain Pediatric Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Print this page PRINCETON, N.J.–(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE:BMY) today announced the U.S. Food and Drug Administration (FDA) has expanded the indication for Sprycel ® (dasatinib) tablets to include the treatment of pediatric patients one year of age and older with newly diagnosed Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) in combination with chemotherapy.1 Sprycel… Read More »

Low Tidal Volume Ventilation Trial in Acute Respiratory Failure Not Feasible

December 17, 2018 Share this content: The trial would need to enroll approximately 107,373 patients to have a 96% power to detect a 3% improvement in mortality at 80% to 100% adherence to low tidal volume ventilation. A cluster-randomized clinical trial of low tidal volume ventilation vs usual care in patients with acute respiratory failure… Read More »